Cargando…

Histone deacetylase 3 promotes alveolar epithelial–mesenchymal transition and fibroblast migration under hypoxic conditions

Epithelial–mesenchymal transition (EMT), a process by which epithelial cells undergo a phenotypic conversion that leads to myofibroblast formation, plays a crucial role in the progression of idiopathic pulmonary fibrosis (IPF). Recently, it was revealed that hypoxia promotes alveolar EMT and that hi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Sung Hwan, Son, Eun Suk, Lee, Young Eun, Kyung, Sun Young, Park, Jeong-Woong, Kim, Se-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355949/ https://www.ncbi.nlm.nih.gov/pubmed/35804191 http://dx.doi.org/10.1038/s12276-022-00796-y

Ejemplares similares

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
por: Kyung, Sun Young, et al.
Publicado: (2018)

Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells
por: Kong, Dejuan, et al.
Publicado: (2012)

Requirement of Histone Deacetylase 6 for Interleukin-6 Induced Epithelial-Mesenchymal Transition, Proliferation, and Migration of Peritoneal Mesothelial Cells
por: Shi, Yingfeng, et al.
Publicado: (2021)

ER Stress is Involved in Epithelial-To-Mesenchymal Transition of Alveolar Epithelial Cells Exposed to a Hypoxic Microenvironment
por: Delbrel, Eva, et al.
Publicado: (2019)

Combination Effect of Silver Nanoparticles and Histone Deacetylases Inhibitor in Human Alveolar Basal Epithelial Cells
por: Gurunathan, Sangiliyandi, et al.
Publicado: (2018)

Regulation of cellular contractile force, shape and migration of fibroblasts by oncogenes and Histone deacetylase 6
por: López-Guajardo, Ana, et al.
Publicado: (2023)

A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer
por: Sakamoto, Takuya, et al.
Publicado: (2016)

The Phosphodiesterase 4 Inhibitor Roflumilast Protects against Cigarette Smoke Extract-Induced Mitophagy-Dependent Cell Death in Epithelial Cells
por: Kyung, Sun Young, et al.
Publicado: (2018)

The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial–mesenchymal transition of lens epithelial cells
por: Chen, X, et al.
Publicado: (2013)

Histone deacetylase 3 deletion in alveolar type 2 epithelial cells prevents bleomycin-induced pulmonary fibrosis
por: Xiong, Rui, et al.
Publicado: (2023)

Inhibition of Histone Deacetylase Impacts Cancer Stem Cells and Induces Epithelial-Mesenchyme Transition of Head and Neck Cancer
por: Giudice, Fernanda S., et al.
Publicado: (2013)

Histone deacetylase 6 inhibition counteracts the epithelial–mesenchymal transition of peritoneal mesothelial cells and prevents peritoneal fibrosis
por: Xu, Liuqing, et al.
Publicado: (2017)

Histone deacetylase 3 controls lung alveolar macrophage development and homeostasis
por: Yao, Yi, et al.
Publicado: (2020)

Structural basis of the specific interaction of SMRT corepressor with histone deacetylase 4
por: Park, Suk-Youl, et al.
Publicado: (2018)

CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma
por: Chang, Young, et al.
Publicado: (2020)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1
por: Cha, Byong-Ki, et al.
Publicado: (2016)

Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer
por: Wu, Sheng-Mao, et al.
Publicado: (2022)

Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial–mesenchymal transition in retinal pigment epithelium cells
por: Xiao, Wei, et al.
Publicado: (2014)

Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors
por: Su, Yanrong, et al.
Publicado: (2018)

Metformin and histone deacetylase inhibitor based anti-inflammatory nanoplatform for epithelial-mesenchymal transition suppression and metastatic tumor treatment
por: Jiang, Tianze, et al.
Publicado: (2022)

Histone Deacetylase Inhibitor Therapy in Epithelial Ovarian Cancer
por: Takai, Noriyuki, et al.
Publicado: (2010)

Histone Deacetylase 9: Its Role in the Pathogenesis of Diabetes and Other Chronic Diseases
por: Hu, Siqi, et al.
Publicado: (2020)

Epigenetic Role of Histone Lysine Methyltransferase and Demethylase on the Expression of Transcription Factors Associated with the Epithelial-to-Mesenchymal Transition of Lung Adenocarcinoma Metastasis to the Brain
por: Lee, Young Min, et al.
Publicado: (2020)

Histone deacetylase 4 reverses cellular senescence via DDIT4 in dermal fibroblasts
por: Lee, Yuri, et al.
Publicado: (2022)

Apolipoprotein A1 Inhibits TGF-β1–Induced Epithelial-to-Mesenchymal Transition of Alveolar Epithelial Cells
por: Baek, Ae Rin, et al.
Publicado: (2016)

A short guide to histone deacetylases including recent progress on class II enzymes
por: Park, Suk-Youl, et al.
Publicado: (2020)

Coix lacryma-jobi var. ma-yuen Stapf sprout extract induces cell cycle arrest and apoptosis in human cervical carcinoma cells
por: Son, Eun Suk, et al.
Publicado: (2019)

Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype
por: Lecce, Laura, et al.
Publicado: (2021)

Regulation of endothelial-to-mesenchymal transition by histone deacetylase 3 posttranslational modifications in neointimal hyperplasia
por: Chen, Lifang, et al.
Publicado: (2023)

Dual Inhibitors Against Topoisomerases and Histone Deacetylases
por: Seo, Young Ho
Publicado: (2015)

Migration, Proliferation, and Differentiation of Cord Blood Mesenchymal Stromal Cells Treated with Histone Deacetylase Inhibitor Valproic Acid
por: Marquez-Curtis, Leah A., et al.
Publicado: (2014)

The Role of Histone Variants in the Epithelial-To-Mesenchymal Transition
por: Lone, Imtiaz Nisar, et al.
Publicado: (2020)

Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization
por: Zhou, Xun, et al.
Publicado: (2023)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties
por: Wawruszak, Anna, et al.
Publicado: (2019)

Carbocisteine Improves Histone Deacetylase 2 Deacetylation Activity via Regulating Sumoylation of Histone Deacetylase 2 in Human Tracheobronchial Epithelial Cells
por: Song, Yun, et al.
Publicado: (2019)

β-Peltoboykinolic Acid from Astilbe rubra Attenuates TGF-β1-Induced Epithelial-to-Mesenchymal Transitions in Lung Alveolar Epithelial Cells
por: Bang, In Jae, et al.
Publicado: (2019)

Redirection of Epithelial Immune Responses by Short-Chain Fatty Acids through Inhibition of Histone Deacetylases
por: Lin, May Young, et al.
Publicado: (2015)

The relationship between cisplatin resistance and histone deacetylase isoform overexpression in epithelial ovarian cancer cell lines
por: Kim, Min-Gyun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_23rfplkrb64kuobgc2omurcju0